Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-03-08 Trizzino John SVP, CBO and CFO Exercise or conversion · Restricted Stock Units −468 0
2020-03-08 Glenn Gregory M President, R&D Exercise or conversion +760 2,133
2020-03-08 Glenn Gregory M President, R&D Shares withheld for taxes −294 $12.48 $4K 1,839
2020-03-08 Glenn Gregory M President, R&D Exercise or conversion · Restricted Stock Units −760 0
2020-03-08 Erck Stanley C President and CEO Exercise or conversion +6,072 22,486
2020-03-08 Erck Stanley C President and CEO Shares withheld for taxes −1,992 $12.48 $25K 20,494
2020-03-08 Erck Stanley C President and CEO Exercise or conversion · Restricted Stock Units −6,072 0
2020-01-31 Glenn Gregory M President, R&D Purchase +1,250 $3.86 $5K 1,373
2019-12-12 YOUNG JAMES F Director Grant or award · Stock Option (Right to buy) +37,500 37,500
2019-12-12 MCMANUS MICHAEL A JR Director Grant or award · Stock Option (Right to buy) +18,000 18,000
2019-12-12 King Rachel K. Director Grant or award · Stock Option (Right to buy) +18,000 18,000
2019-09-26 Glenn Gregory M President, R&D Grant or award · Stock Appreciation Right +66,100 66,100
2019-09-26 Erck Stanley C President and CEO Grant or award · Stock Appreciation Right +100,000 100,000
2019-09-26 Trizzino John EVP, CBO and CFO Grant or award · Stock Appreciation Right +18,400 18,400

Page 87 of 87 · 1,734 trades